OrisDX
company
About
OrisDX provides a saliva-based molecular detection method to check oral cavity pre-malignancies and cancers.
- 1 - 10
Details
- Last Funding Type
- Grant
- Last Funding Money Raised
- $200K
- Industries
- Biotechnology,Medical
- Number Of Employee
- 1 - 10
- Operating Status
- Active
OrisDX provides a saliva-based molecular detection method to check oral cavity pre-malignancies and cancers.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$200K
OrisDX has raised a total of
$200K
in funding over 2 rounds. Their latest funding was raised on
Jul 5, 2022 from a Grant round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jul 5, 2022 | Grant | $200K | 1 |
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
OrisDX is funded by 1 investors.
George Shultz Innovation Fund
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
Yes | Grant |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
